Pulmonx Corp LUNG
Pulmonx Corp statistics & valuation
Market cap$52.8M
P / S0.6×
P / B1.0×
Net margin-59.7%
Return on equity-99.8%
FCF margin-36.3%
Net cash$32.7M
Enterprise value USD$20.1M
Return on capital-49.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Gross margin | 74.2% | 74.0% | 73.9% | 74.3% | 73.6% | 64.8% | 68.8% |
| Operating margin | -59.3% | -68.9% | -90.2% | -109.3% | -97.7% | -98.8% | -54.7% |
| Net margin | -59.7% | -67.3% | -88.6% | -109.8% | -100.5% | -98.5% | -63.5% |
| FCF margin | -36.3% | -39.4% | -55.9% | -86.5% | -93.1% | -96.4% | -65.9% |
| Return on assets | -41.8% | -34.6% | -34.2% | -30.4% | -20.7% | -12.2% | -38.7% |
| Return on equity | -99.8% | -65.7% | -51.4% | -38.3% | -25.2% | -14.3% | 11.0% |
| Debt / equity | 0.69× | 0.43× | 0.31× | 0.11× | 0.09× | 0.08× | — |
| Current ratio | 5.07 | 5.58 | 6.50 | 9.14 | 11.85 | 19.96 | 2.90 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.